by Marybeth Burke – The investigational agent trastuzumab emtansine (T-DM1) demonstrated improved efficacy over capecitibine plus lapatinib and improved progression-free survival (PFS) in women with HER2-positive locally advanced… read more.
by Marybeth Burke – Wisconsin grown ginseng significantly reduced cancer related fatigue in patients receiving cancer treatment after 8 weeks of ginseng treatment,
by Marybeth Burke – Afatinib, an irreversible ErbB-family blocker, delays progression of advanced lung cancer in patients with epidermal growth factor receptor (EGFR) mutations compared with standard chemotherapy,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.
by Bruce Sylvester – taken from The New England Journal of Medicine (NEJM) – Women treated with anastrozole and fulvestrant combination therapy have achieved over 6 months median… read more.
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
Serrated polyposis is one of the most common polyp syndromes in clinical practice and is often unrecognized during colonoscopy.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths.
The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.
Women having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other… read more.
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
